Case report: Treatment of catatonia in an adolescent male

Journal of Adolescent Health

Volumn 27, Issue 1, 2000, Pages 69-71

  Delbello, Melissa P ^a   Foster, Keith D ^a   Strakowski, Stephen M ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Adolescent; Atypical antipsychotics; Catatonia; Psychosis; Schizophrenia

Indexed keywords

LORAZEPAM; OLANZAPINE; VALPROIC ACID;

ADOLESCENT; CASE REPORT; CATATONIA; CONFERENCE PAPER; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CATATONIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; PIRENZEPINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034039645     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(00)00109-9     Document Type: Conference Paper

References (19)

1. Mann S.C., Caroff S.N., Bleir H.R., et al. Lethal catatonia. Am J Psychiatry. 143:1986;1374-1381.
2. Dhossche D.M., Bouman N.H. Catatonia in children and adolescents [letter]. J Am Acad Child Adolesc Psychiatry. 36:1997;870-871.
3. Dhossche D., Bouman N. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry. 9:1997;247-253.
4. Petrides G., Divadeenam K.M., Bush G., et al. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry. 42:1997;375-381.
5. Zaw Z.F., Bates G.D.L. Replication of zolpidem test for catatonia in an adolescent. Lancet. 349:1997;114.
6. Kumra S., Jacobsen L.K., Lenane M., et al. Childhood-onset schizophrenia An open-label study of olanzapine in adolescents . J Am Acad Child Adolesc Psychiatry. 37:1988;377-385.
7. Krishnamoorthy J., King B.H. Open-label olanzapine in five preadolescent children. J Child Adolesc Psychopharm. 8:1988;107-113.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
9. Rogers D. Catatonia A contemporary approach . J Neuropsych Clin Neurosci. 3:1991;334-340.
10. Cook E.H., Olson K., Pliskin N. Response of organic catatonia to risperidone. Arch Gen Psychiatry. 53:1996;82-83.
11. Dhossche D., Petrides G. Negative symptoms or catatonia? [letter]. J Am Acad Child Adolesc Psychiatry. 36:1997;302.
12. Zuddas A., Pintor M., Chianchetti C. Risperidone for negative symptoms. J Am Acad Child Adolesc Psychiatry. 35:1996;838-839.
13. Zuddas A., Pintor M., Chianchetti C. In reply. J Am Acad Child Adolesc Psychiatry. 36:1997;302-303.
14. Battegay R., Cotar B., Fleischauer J., et al. Results and side effects of treatment with clozapine. Comp Psychiatry. 18:1977;423-428.
15. Rommel O., Tegenthoff M., Widdig W., et al. Organic catatonia following frontal lobe injury response to clozapine . J Neuropsych Clin Neurosci. 10:1998;237-238.
16. Philbrick K.L., Rummans T.A. Malignant catatonia. J Neuropsych Clin Neurosci. 6:1994;1-13.
17. Gelenberg A.J., Mandel M.R. Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry. 34:1997;947-950.
18. Weller M., Kornhuber J. Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry. 54:1993;70-71.
19. Hawkins J.M., Archer K.J., Strakowski S.M., et al. Somatic treatment of catatonia. Int J Psychiatry Med. 25:1995;345-369.